Medical & Economical Evaluation of Fenestrated & Branched Stent-grafts to Treat Complex Aortic Aneurysms
Windows1
Medical and Economical Evaluation of Endovascular Therapy of Complex Aortic Aneurysms (Para- & Supra- Renal Abdominal Aortic Aneurysms, Type 4 THORACO-Abdominal Aneurysms) by Fenestrated & Branched Stent-grafts
1 other identifier
observational
270
1 country
1
Brief Summary
The aim of this study is to prospectively compare the perioperative mortality severe morbidity and the costs of endovascular versus conventional surgical repair of pararenal, supra-renal and type 4 THORACO-abdominal aortic aneurysms. The primary goal of the study is to demonstrate a significant drop in 30-day mortality and life threatening morbidity in the endovascular arm of the study. Our hypothesis, derived from the literature, that the average 30-days mortality is 3% after endovascular repair and 10% after open surgery justifies the design of a prospective study between endovascular therapy (250 patients (amendment) treated in 8 University hospitals with significant experience of the technique) and open repair (660 similar patients analyzed form the national database of the MOH).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 17, 2009
CompletedFirst Submitted
Initial submission to the registry
July 21, 2010
CompletedFirst Posted
Study publicly available on registry
July 22, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 9, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 9, 2015
CompletedOctober 19, 2017
October 1, 2017
5.7 years
July 21, 2010
October 18, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
30-day postoperative mortality
30-day postoperative
Secondary Outcomes (8)
complications
30-day postoperative
Length of Intensive Care Unit (ICU) stay
30-day postoperative
Length of Hospital stay
30-day postoperative
Overall cost
30-day postoperative
Reinterventions
2-year follow up
- +3 more secondary outcomes
Study Arms (3)
Open repair
Open Surgical Repair (aortic replacement with revascularization of visceral arteries)
Endovascular (Windows 1)
Endovascular therapy branched or fenestrated stent-graft
Endovascular (Windows 3)
Endovascular therapy branched or fenestrated stent-graft (vascutek anaconda)
Interventions
Insertion via bilateral femoral access, stent-graft deployment under fluoroscopic guidance, complementary stenting of visceral arteries, control angiogram
aortic replacement with revascularization of visceral arteries
Eligibility Criteria
All patients with an Abdominal aortic aneurysm over 5 cm in diameter or with a diameter increase over 1 cm in 1 year and a PSRAA defined by: * Infrarenal aortic neck \< 15 mm * or extent of the aneurismal process to the suprarenal aorta
You may qualify if:
- Absence of significant angulations (\< 60°) of aorta or of iliac arteries
- Absence of tight stenosis (\>70%) of more than one target artery (renal or visceral artery to be perfused from the side holes of the stent-graft)
- Diameter of target arteries over 5 mm
- Iliac and femoral arteries allowing insertion of the delivery system (\> 7 mm) or suitable for insertion of an access conduit
You may not qualify if:
- Limited expected life expectancy
- Emergency cases
- Refuse to participate to the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Henri Mondor Hospital
Créteil, 94010, France
Related Publications (4)
O'Neill S, Greenberg RK, Haddad F, Resch T, Sereika J, Katz E. A prospective analysis of fenestrated endovascular grafting: intermediate-term outcomes. Eur J Vasc Endovasc Surg. 2006 Aug;32(2):115-23. doi: 10.1016/j.ejvs.2006.01.015. Epub 2006 Mar 31.
PMID: 16580236BACKGROUNDMichel M, Becquemin JP, Clement MC, Marzelle J, Quelen C, Durand-Zaleski I; WINDOW Trial Participants. Editor's choice - thirty day outcomes and costs of fenestrated and branched stent grafts versus open repair for complex aortic aneurysms. Eur J Vasc Endovasc Surg. 2015 Aug;50(2):189-96. doi: 10.1016/j.ejvs.2015.04.012. Epub 2015 Jun 19.
PMID: 26100447DERIVEDMarzelle J, Presles E, Becquemin JP; WINDOWS trial participants. Results and factors affecting early outcome of fenestrated and/or branched stent grafts for aortic aneurysms: a multicenter prospective study. Ann Surg. 2015 Jan;261(1):197-206. doi: 10.1097/SLA.0000000000000612.
PMID: 24670864DERIVEDBanno H, Kobeiter H, Brossier J, Marzelle J, Presles E, Becquemin JP. Inter-observer variability in sizing fenestrated and/or branched aortic stent-grafts. Eur J Vasc Endovasc Surg. 2014 Jan;47(1):45-52. doi: 10.1016/j.ejvs.2013.10.008. Epub 2013 Oct 23.
PMID: 24268517DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Pierre Becquemin, PU-PH
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2010
First Posted
July 22, 2010
Study Start
June 17, 2009
Primary Completion
February 9, 2015
Study Completion
February 9, 2015
Last Updated
October 19, 2017
Record last verified: 2017-10